Scientific Online Resource System

Journal of the Union of Scientists - Varna. Medicine and Ecology Series

Correlation analysis of prostate cancer incidence and mortality worldwide, in Europe and in Bulgaria

Kalin Kalchev


An in-depth overview of the prostate cancer incidence and mortality rates, based on the geographical location, race and ethnicity on global, European and national scales, shows ambiguous, incompatible and sometimes unreliable data. The aim of this study is to analyze the incidence and mortality rates worldwide, in Europe and in Bulgaria. Data from global databases (Globocan) and the National Statistical Institute of Bulgaria are used. The global incidence and mortality rates of prostate cancer correlate with age. The median age at the time of the diagnosis is 66 years. International trends in prostate cancer incidence and mortality have varied significantly in recent years, closely related to the PSA screening used for early detection of the disease, mostly in the Western countries. Data sources show a discrepancy in the incidence and mortality rates in men of different races and geographical origins. This confirms the role of genetic factors in the pathogenesis of prostate cancer. Discrepancies between men of the same race and ethnicity, living in different countries, suggests that other factors such as diet and socioeconomic status, different methods of diagnosis and treatment are also important. The highest incidence rate is expected in the developed countries and the highest mortality rate in the developing countries.


prostate cancer, prostate cancer incidence and mortality rates

Full Text


Baade, P. D., Youlden, D. R., & Krnjacki, L. J. (2009). International epidemiology of prostate cancer: Geographical distribution and secular trends. Molecular Nutrition and Food Research, 53(2), 171–184. doi:10.1002/mnfr.200700511

Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394–424

Center, M. M., Jemal, A., Lortet-Tieulent, J., Ward, E., & Ferlay, J. (2012). International variation in prostate cancer incidence and mortality rates. European Urology, 61(6), 1079–1092. doi:10.1016/j.eururo.2012.02.054

Chu, L. W., Ritchey, J., Devesa, S. S., Quraishi, S. M., Zhang, H., & Hsing, A. W. (2011). Prostate cancer incidence rates in Africa. Prostate Cancer, 2011, 1–6. doi:10.1155/2011/947870

De Angelis R, Sant M, Coleman MP, Francisci S, Baili P, Pierannunzio D, Trama A. et al. Cancer survival in Europe 1999-2007 by country and age: results of EUROCARE—5-a population-based study. Lancet Oncol. 2014;15(1):23–34

Ferlay J EM, Lam F, Colombet M, Mery L, Pineros M, Znaor A, Soerjomataram I. et al. Global cancer observatory: cancer today. Lyon, France: International Agency for Research on Cancer. Available from:, Accessed 02 February 2019

Hsing, A. W., & Devesa, S. S. (2001). Trends and patterns of prostate cancer: What do they suggest? Epidemiology Review, 23(1), 60–67

Jemal, A., Center, M. M., DeSantis, C., & Ward, E. M. (2010). Global patterns of cancer incidence and mortality rates and trends. Cancer Epidemiology Biomarkers and Prevention, 19(8), 1893–1907. doi:10.1158/1055-9965.EPI-10-0437

Kambal, A. (1977). Prostatic obstruction in Sudan. British Journal of Urology, 49(2), 139–141

Mottet, N., Bellmunt, J., Bolla, M., Briers, E., Cumberbatch, M. G., De Santis, M., Lam, T. B. (2017). EAU-ESTROSIOG guidelines on prostate cancer. Part 1: Screening, diagnosis, and local treatment with curative intent. European Urology, 71(4), 618–629

Negoita, S., Feuer, E. J., Mariotto, A., Cronin, K. A., Petkov, V. I., Hussey, S. K., Sherman, R. L. (2018). Annual report to the nation on the status of cancer, part II: Recent changes in prostate cancer trends and disease characteristics. Cancer, 124(13), 2801–2814. doi:10.1002/cncr.31549

Panigrahi GK, Praharaj PP, Kittaka H, Mridha AR, Black OM, Singh R, Mercer R. et al. Exosome proteomic analyses identify inflammatory phenotype and novel biomarkers in African American prostate cancer patients. Cancer Med. 2019

Parkin, D. M., Ferlay, J., Hamdi-Chirif, M., Sitas, F., Thomas, J. O., Wabinga, H., Whelan, S. L. (Eds.). (2003). Cancer in Africa: Epidemiology and prevention. 153 Lyons. France: IARC Scientific Publications

Perdana NR, Mochtar CA, Umbas R, Hamid AR. The Risk Factors of Prostate Cancer and Its Prevention: A Literature Review. Acta Med Indones. 2016;48(3):228–238

Quinn, M., & Babb, P. (2002). Patterns and trends in prostate cancer incidence, survival, prevalence and mortality. Part I: International comparisons. British Journal of Urology International, 90(2), 162–173. doi:10.1046/j.1464-410X.2002.2822.x

Taitt HE. Global Trends and Prostate Cancer: A review of incidence, detection, and mortality as influenced by race, ethnicity, and geographic location. Am J Mens Health. 2018;12(6):1807–1823

Torre, L .A., Bray, F., Siegel, R., Ferlay, J., Lortet-Tievlent, J., & Jemal, A. J. (2015). Global cancer statistics, 2012. doi:10.3322/caac.21262



Font Size